Results 141 to 150 of about 142,936 (266)

A Fatal Case Involving Chronic Intravenous Use of Homemade Methcathinone Derived from Pseudoephedrine Tablets: Post-Mortem Concentrations, Health Risk, and Medicolegal Aspect. [PDF]

Int J Mol Sci
Nowak K, Szpot P, Zawadzki M.
europepmc   +1 more source

Current status of substance abuse and HIV infection in Japan.

Journal of Food and Drug Analysis, 2013
K. Wada, M. Funada, T. Shimane
semanticscholar   +1 more source

Swallowing and Communication in Cockayne Syndrome: Clinical Characteristics and Management

American Journal of Medical Genetics Part A, Volume 200, Issue 7, Page 1465-1478, July 2026.
ABSTRACT Cockayne syndrome (CS) is an ultrarare genetic disorder associated with genes encoding proteins involved in DNA repair. The clinical course of CS involves neurodevelopmental and neurodegenerative features, including swallowing and communication impairments.
Abigail M. Spoden, Katlyn E. McGrattan, Peter B. Kang   +2 more
wiley   +1 more source

When delay costs a limb: Severe chronic osteomyelitis in a patient with intravenous drug use. [PDF]

Trauma Case Rep
Vieira LF, Cardinal PR, Gibbs L, Henry SM, Ribeiro MAF.   +4 more
europepmc   +1 more source

Drug Critical Limits for Urgent Physician Notification

Clinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 178-192, July 2026.
Critical limits represent quantitative decision thresholds for drugs that require immediate clinician notification and potential life‐saving intervention. United States hospitals lack a national standard for drug critical limits. We collected critical limits from 417 US hospitals across all 50 states and Washington, D.C.; of these, 411 maintained drug ...
Elina Kuang, Yasmeen Ibrahim, Kyle Cheng, Gerald J. Kost   +3 more
wiley   +1 more source

The need to incorporate polysubstance use in neuropsychopharmacology research: Biological lessons and new opportunities. [PDF]

Addict Neurosci
Joffe ME, Ferguson SM, Gilpin NW, Herman MA, Knackstedt LA, Randall PA, Schindler AG, Torregrossa MM, Rinker JA.   +8 more
europepmc   +1 more source

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review

Clinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 94-108, July 2026.
Interest in ayahuasca and its main component, N,N‐Dimethyltryptamine (DMT), has currently moved from historical and experimental use into modern clinical development. Yet, current evidence is fragmented, and systematic mapping of trial methods and design choices remains limited.
Tijana Stojanović, Kent W. Nilsson, Robert Fredriksson, Helgi B. Schiöth, Thiago C. Moulin   +4 more
wiley   +1 more source

Moving beyond shock: Rich-lean transition procedures as a modern approach to anxiolytic screening. [PDF]

J Pharmacol Exp Ther
Rough MI, Kratzenberg JL.
europepmc   +1 more source

Using peri‐operative patient‐ and parent‐reported experience and outcome measures to identify paediatric postsurgical recovery trajectories: an observational cohort study

Anaesthesia, Volume 81, Issue 7, Page 959-971, July 2026.
Summary Introduction Identifying postoperative pain trajectories and pre‐operative risk factors may support preventative measures and enhance pain management. We aimed to determine the feasibility of gathering peri‐operative data from families of children, describe their recovery trajectories and identify risk factors for high postsurgical pain ...
Samantha Pang, Nicholas West, Haoyu Zhao, Jessica Luo, Neil K. Chadha, Lynnie R. Correll, Heng Gan, Matthias Görges   +7 more
wiley   +1 more source

Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics. [PDF]

J Psychopharmacol
Henningfield JE, Barrett FS, Evans SM, Garcia-Romeu A, Garrett BE, Hienz RD, Lukas SE, Nayak SM, Strain EC, Weerts EM, Yaden ME, Yaden DB.   +11 more
europepmc   +1 more source